News in Brief

Malaria drug made by baker's yeast

Fermentation process could become important new production method for artemisinin

12:30pm, April 11, 2013

Using genetically engineered baker’s yeast, researchers have come up with a shortcut to making artemisinin, a frontline drug against malaria. Christopher Paddon of Amyris Inc. of Emeryville, Calif., and his colleagues describe their process April 10 in Nature.  

Last year the team reported that they could ferment the bioengineered yeast to make amorphadiene, a precursor of artemisinic acid. In the new study, they improve the yield of the precursor and then spell out a process for converting artemisinic acid to artemisinin itself. The researchers say the overall strategy could streamline artemisinin manufacturing.

This article is available only to subscribing members. Join SSP today or Log in.

More from this issue of Science News